A study evaluating safety of Sunitinib and Sorafenib.
Latest Information Update: 13 Feb 2018
At a glance
- Drugs Sorafenib (Primary) ; Sunitinib (Primary) ; Capecitabine
- Indications Cancer
- Focus Adverse reactions
- 13 Feb 2018 New trial record
Latest Information Update: 13 Feb 2018